|Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer|
International Adjuvant Lung Cancer Trial Collaborative Group
New England Journal of Medicine 350 (4), 351-360, 2004
|CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by …|
M Pfreundschuh, L Trümper, A Österborg, R Pettengell, M Trneny, K Imrie, ...
The lancet oncology 7 (5), 379-391, 2006
|DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy|
KA Olaussen, A Dunant, P Fouret, E Brambilla, F André, V Haddad, ...
New England Journal of Medicine 355 (10), 983-991, 2006
|A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy|
RA Olie, AP Simões-Wüst, B Baumann, SH Leech, D Fabbro, RA Stahel, ...
Cancer research 60 (11), 2805-2809, 2000
|Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma|
A Scherpereel, P Astoul, P Baas, T Berghmans, H Clayson, P De Vuyst, ...
European Respiratory Journal 35 (3), 479-495, 2010
|CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the …|
M Pfreundschuh, E Kuhnt, L Trümper, A Österborg, M Trneny, L Shepherd, ...
The lancet oncology 12 (11), 1013-1022, 2011
|Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non–small-cell lung cancer: a …|
DC Betticher, SF Hsu Schmitz, M Totsch, E Hansen, C Joss, C Von Briel, ...
Journal of clinical oncology 21 (9), 1752-1759, 2003
|CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells|
S Aigner, ZM Sthoeger, M Fogel, E Weber, J Zarn, M Ruppert, Y Zeller, ...
Blood, The Journal of the American Society of Hematology 89 (9), 3385-3395, 1997
|Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes|
T Le Chevalier, G Scagliotti, R Natale, S Danson, R Rosell, R Stahel, ...
Lung cancer 47 (1), 69-80, 2005
|Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma|
W Weder, RA Stahel, J Bernhard, S Bodis, P Vogt, P Ballabeni, ...
Annals of oncology 18 (7), 1196-1202, 2007
|2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up|
J Vansteenkiste, L Crinò, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ...
Annals of Oncology 25 (8), 1462-1474, 2014
|Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop|
R Pirker, FJF Herth, KM Kerr, M Filipits, M Taron, D Gandara, FR Hirsch, ...
Journal of Thoracic Oncology 5 (10), 1706-1713, 2010
|Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation|
S Hopkins-Donaldson, A Ziegler, S Kurtz, C Bigosch, D Kandioler, ...
Cell Death & Differentiation 10 (3), 356-364, 2003
|CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment …|
J Lundin, A Osterborg, G Brittinger, D Crowther, H Dombret, A Engert, ...
Journal of Clinical Oncology 16 (10), 3257-3263, 1998
|2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer|
WEE Eberhardt, D De Ruysscher, W Weder, C Le Péchoux, P De Leyn, ...
Annals of Oncology 26 (8), 1573-1588, 2015
|Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma|
W Weder, P Kestenholz, C Taverna, S Bodis, D Lardinois, M Jerman, ...
Journal of clinical oncology 22 (17), 3451-3457, 2004
|Circulating DNA: a new diagnostic gold mine?|
A Ziegler, U Zangemeister-Wittke, RA Stahel
Cancer treatment reviews 28 (5), 255-271, 2002
|Circulating deoxyribonucleic acid as prognostic marker in non–small-cell lung cancer patients undergoing chemotherapy|
O Gautschi, C Bigosch, B Huegli, M Jermann, A Marx, E Chassé, ...
Journal of Clinical Oncology 22 (20), 4157-4164, 2004
|High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule …|
J Willuda, A Honegger, R Waibel, PA Schubiger, R Stahel, ...
Cancer research 59 (22), 5758-5767, 1999
|Staging and prognostic factors in small cell lung cancer: a consensus report|
RAR Stahel, R Ginsberg, K Havemann, FR Hirsch, D Ihde, J Jassem, ...
Lung cancer 5 (4-6), 119-126, 1989